BIOCARTIS news, videos and press releases - Page 7
For more news please use our advanced search feature.
BIOCARTIS - More news...
BIOCARTIS - More news...
- Biocartis Group NV: Biocartis announces 2017 half-year results on 7 September 2017
- Biocartis Group NV: Strong performance data of proprietary MSI Biomarkers for the Idylla(TM) MSI Test to be published at ESMO
- Biocartis Group NV: Biocartis announces 2017 half-year results on 7 September 2017
- Biocartis Group NV: Strong performance data of proprietary MSI Biomarkers for the Idylla(TM) MSI Test to be published at ESMO
- Biocartis Group NV: Invitation to the extraordinary shareholders' meeting
- Biocartis' Idylla(TM) Instrument and Idylla(TM) Console exempt from US FDA 510(k) notification requirements
- Biocartis Group NV: Biocartis' Idylla(TM) Instrument and Idylla(TM) Console exempt from US FDA 510(k) notification requirements
- Biocartis Group NV: Biocartis and A*STAR's ETPL initiate development of breast cancer assay to guide therapy selection
- Biocartis Group NV: Disclosure of a transparency notification
- Biocartis Group NV: Biocartis launches CE-marked IVD test for lung cancer
- Biocartis Group NV: MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer
- Biocartis Group NV: Disclosure of a transparency notification
- Biocartis Group NV: Biocartis launches CE-marked IVD NRAS test for colorectal cancer
- Biocartis Group NV: Biocartis establishes US subsidiary and appoints US General Manager
- Biocartis Group